A Short Term Study of Nutritional Effect of Intraperitoneal Amino Acid in CAPD Patients

王军,俞雨生,贾忠辉,唐政,刘志红,黎磊石

DOI: https://doi.org/10.3969/j.issn.1006-298x.2004.04.007

2004-01-01

Abstract:Objective:Nutritional complications is an important prognosis factor for continuous ambulatory peritoneal dialysis (CAPD) patients. In this study, we investigated the short term effects of intraperitoneal amino acid solution in CAPD patients for six months. Methodology:Twenty-four CAPD patients were enrolled in this study, and randomly divided into the treatment group and the control group(12 in each). In the treatment group, during the day-time exchange of dialysate, each patient recieved a bag of dialysate(1.5% Dianeal) enriched with 100ml branch-chain amino acid. The control group, patients continued their CAPD with the same dialysate(1.5% Dianeal) as usual. All the patients were followed-up in this study for six months. Serum levels of albumin, transferrin, prealbumin were determined monthly. Nutritional parameters as nPNA(the normalized protein equivalent of nitrogen appearance), %LMB(percentage of lean body mass), MAMC(middle-arm muscle circumference) and TSF(triceps skinfold)were assessed during the study. Results:In the treatment group, serum level of albumin increased significantly as compared with the baseline level[(38.67±6.81)g/L vs (42.44±3.60)g/L, P0.05] after three months of treatment. Serum levels of transferrin[(2.74±0.37)g/L vs (2.93±0.16)g/L, P0.05] and prealbumin [(461.38±330.29)g/L vs (641.57±673.91)g/L,P0.05] were also found increased after three months of treatment and being stable thereafter. While in the control group, serum levels of transferrin [baseline vs 6-month:(2.51±0.47)g/L vs (2.41±0.53)g/L] and prealbumin [baseline vs 6-month: (450.12±286.31)g/L vs (351.58±172.36)g/L] declined singnificantly. Nutritional parameters as nPNA?%LBM and MAMC were stable throughout the study in the treatment group, while reduced singificantly in the control group (nPNA: 0.9612±0.13 vs 0.9426±0.17, P0.05; %LBM: 0.6849±0.02 vs 0.6452±0.04,P0.05) after the study. No significant difference in adequcy parameters of dialysis were found during the study. Triglycerides [baseline vs 6-month: (1.58±0.95)mmol/L vs (2.17±0.78)mmol/L,P0.05] and total cholesterol [baseline vs 6-month: (5.78±2.10)mmol/L vs (6.12±1.05)mmol/L,P0.05] increased significantly in the control group, while in the treatment group triglycerides decreased at the end of study[(1.66±0.94)mmol/L vs (1.52±0.56)mmol/L,P0.05]. No side effect and discomfirt complains were found in any patient of the treatment group during the dwelling of the amino acid enriched dialysate. Conclusion:Administration of amino acid enriched dialysate (1.5% dextrose) is a safe maneuver and a effective means to improve nutritional status in CAPD patients.